Correlation Between Vaxcyte and Immunocore Holdings

Can any of the company-specific risk be diversified away by investing in both Vaxcyte and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vaxcyte and Immunocore Holdings, you can compare the effects of market volatilities on Vaxcyte and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and Immunocore Holdings.

Diversification Opportunities for Vaxcyte and Immunocore Holdings

0.63

Correlation Coefficient

Vaxcyte  Immunocore Holdings

Poor diversification

The 3 months correlation between Vaxcyte and Immunocore is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Vaxcyte i.e., Vaxcyte and Immunocore Holdings go up and down completely randomly.

Pair Corralation between Vaxcyte and Immunocore Holdings

Given the investment horizon of 90 days Vaxcyte is expected to under-perform the Immunocore Holdings. In addition to that, Vaxcyte is 1.28 times more volatile than Immunocore Holdings. It trades about -0.08 of its total potential returns per unit of risk. Immunocore Holdings is currently generating about -0.05 per unit of volatility. If you would invest  3,274  in Immunocore Holdings on November 28, 2024 and sell it today you would lose (256.00) from holding Immunocore Holdings or give up 7.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vaxcyte  vs.  Immunocore Holdings

Vaxcyte

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Immunocore Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Vaxcyte and Immunocore Holdings

The main advantage of trading using opposite Vaxcyte and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.

The idea behind Vaxcyte and Immunocore Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.